4.2 Article

The primary care physician role in cancer genetics: a qualitative study of patient experience

Journal

FAMILY PRACTICE
Volume 27, Issue 5, Pages 563-569

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/fampra/cmq035

Keywords

Cancer; genetics; primary care; qualitative research

Funding

  1. Institute of Health Services and Policy Research of the Canadian Institutes of Health Research [80495]
  2. Sydney G. Frankfort Chair in Family Medicine

Ask authors/readers for more resources

Background. Increased availability of genetic testing is changing the primary care role in cancer genetics. The perspective of primary care physicians (PCPs) regarding their role in support of genetic testing has been explored, but little is known about the expectations of patients or the PCP role once genetic test results are received. Methods. Two sets of open-ended semi-structured interviews were completed with patients (N = 25) in a cancer genetic programme in Ontario, Canada, within 4 months of receiving genetic test results and 1 year later; written reports of test results were collected. Results. Patients expected PCPs to play a role in referral for genetic testing; they hoped that PCPs would have sufficient knowledge to appreciate familial risk and supportive attitudes towards genetic testing. Patients had more difficulty in identifying a PCP role following receipt of genetic test results; cancer patients in particular emphasized this as a role for cancer specialists. Still, some patients anticipated an ongoing PCP role comprising risk-appropriate surveillance or reassurance, especially as specialist care diminished. These expectations were complicated by occasional confusion regarding the ongoing care appropriate to genetic test results. Conclusions. The potential PCP role in cancer genetics is quite broad. Patients expect PCPs to play a role in risk identification and genetics referral. In addition, some patients anticipated an ongoing role for their PCPs after receiving genetic test results. Sustained efforts will be needed to support PCPs in this expansive role if best use is to be made of investments in cancer genetic services.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

The Consultant?s intermediary role in the regulation of molecular diagnostics in the US

Kelly Holloway, Fiona A. Miller

Summary: This article investigates the regulatory regime for molecular diagnostics in the US, highlighting the key role of private consultants in coverage and reimbursement. The study emphasizes the production of evidence as a critical part of the process and argues that consultants act as regulatory intermediaries, benefiting their clients' financial interests. The article suggests that public policy discussions should reconsider whose interests are represented in the regulatory regime.

SOCIAL SCIENCE & MEDICINE (2022)

Article Pediatrics

Policy Rogue or Policy Entrepreneur? The Forms and Impacts of Joined-Up Governance for Child Health

Celine Cressman, Fiona A. Miller, Astrid Guttmann, John Cairney, Robin Z. Hayeems

Summary: Joined-up governance (JUG) approaches have gained attention as mechanisms for tackling wicked policy problems, particularly in intersectoral areas such as child health. Investments in early childhood development, such as developmental screening, illustrate the challenges of JUG for child health.

CHILDREN-BASEL (2021)

Article Business

Moving toward responsible value creation: Business model challenges faced by organizations producing responsible health innovations

Pascale Lehoux, Hudson P. Silva, Jean-Louis Denis, Fiona A. Miller, Renata Pozelli Sabio, Marguerite Mendell

Summary: This study aims to explore the challenges that Responsible Research and Innovation (RRI) poses to business models and value creation. Through multiple case studies, it was found that organizations face business model challenges from micro-, meso-, and macro-levels when trying to achieve responsible innovation, which affects the implementation of their business models and their capacity for responsible value creation.

JOURNAL OF PRODUCT INNOVATION MANAGEMENT (2021)

Article Ethics

The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility

Kelly Holloway, Nicole Simms, Robin Z. Hayeems, Fiona A. Miller

Summary: This study analyzes the marketing of noninvasive prenatal testing (NIPT) and identifies concerns regarding bias, misrepresentation, and lack of regulatory oversight. The findings highlight the potential for commercial imperatives to exacerbate issues in marketing materials.

HASTINGS CENTER REPORT (2022)

Article Health Care Sciences & Services

Differing Conceptualizations of the Goals of Care Discussion: A Critical Discourse Analysis

Jeff Myers, Ginah L. Kim, Jessica Bytautas, Fiona Webster

Summary: This study used critical discourse analysis to examine GOCDs documented by Canadian physicians in palliative medicine, critical care medicine, and general internal medicine. The study found differing conceptualizations of the GOCD, with goals being oriented towards either the person or the treatment.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2022)

Review Public, Environmental & Occupational Health

Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions

M. Richardson, A. Erman, N. Daneman, F. A. Miller, B. Sander

Summary: This study assessed how the scope of the decision problem is defined in economic evaluations of interventions for Clostridioides difficile infection. Most studies focused on a single intervention, while only a few considered the relationship between multiple interventions. This has important implications for optimal allocation of healthcare resources.

JOURNAL OF HOSPITAL INFECTION (2022)

Article Genetics & Heredity

Use of eConsult to enhance genetics service delivery in primary care: A multimethod study

June C. Carroll, Clare Liddy, Amir Afkham, Erin Keely, Elaine S. Goh, Gail E. Graham, Joanne A. Permaul, Judith Allanson, Ruth Heisey, Tutsirai Makuwaza, Donna P. Manca, Mary Ann O'Brien, Eva Grunfeld

Summary: The study aimed to investigate the effectiveness of electronic consultation (eConsult) in improving genetics service delivery in primary care. The results showed that eConsult provided timely genetics advice, helped avoid unnecessary patient referrals, and was perceived as valuable for patient management. However, for greater impact on access and wait times, systematic integration of eConsult into primary care providers and geneticists' practice is needed.

GENETICS IN MEDICINE (2022)

Editorial Material Public, Environmental & Occupational Health

Multidisciplinary perspectives on the regulation of diagnostic technologies Introduction

Stuart Hogarth, Fiona A. Miller, Steve Sturdy

SOCIAL SCIENCE & MEDICINE (2022)

Review Health Care Sciences & Services

Grief and bereavement of family and friends around medical assistance in dying: scoping review

Han Yan, Jessica Bytautas, Sarina Roslyn Isenberg, Ari Kaplan, Narges Hashemi, Mona Kornberg, Tekla Hendrickson

Summary: This study reviewed the literature on the grief and bereavement of family and friends following medical assistance in dying (MAiD), and identified several factors that impact their experience. The findings suggest that support is needed to address the complex and changing emotions of family and friends before, during, and after a MAiD death. Additionally, normalizing MAiD in society and reducing secrecy and stigma are necessary to improve the accessibility of resources for family and friends.

BMJ SUPPORTIVE & PALLIATIVE CARE (2022)

Article Health Policy & Services

An urgent call for the environmental sustainability of health systems: A 'sextuple aim' to care for patients, costs, providers, population equity and the planet

Hassane Alami, Pascale Lehoux, Fiona A. A. Miller, Sara E. E. Shaw, Jean-Paul Fortin

Summary: Health systems have a responsibility to protect the health and well-being of individuals and populations, but healthcare contributes to a significant percentage of global greenhouse gas emissions. This paper examines the potential integration of "environmental sustainability" into the concept of the "Sextuple Aim" and explores the challenges and opportunities of incorporating environmental sustainability into healthcare goals. The authors propose policy and practical approaches to help healthcare systems move towards achieving the Sextuple Aim.

INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2023)

Article Health Care Sciences & Services

A comparative analysis of non-invasive prenatal testing in Ontario and Quebec: the role of governing style in health technology innovation & adoption

Lena Saleh, Gillian Parker, Michael Stevenson, Fiona A. Miller

BMC HEALTH SERVICES RESEARCH (2023)

Review Multidisciplinary Sciences

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review

Gillian Z. Parker, Sarah Hunter, Samer A. Ghazi, Robin Z. Hayeems, Francois Rousseau, Fiona A. Miller

Summary: Decision impact studies in genomic medicine have become increasingly prevalent in cancer care. These studies aim to evaluate the impact of genomic tests on treatment decisions and provide evidence of clinical utility. This scoping review identified and characterized 87 studies reporting on different types of clinical utility outcomes.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studies

Gillian A. Parker, Sarah Hunter, Stuart Hogarth, Fiona Miller

Summary: This study analyzes the importance of decision impact studies in genomic medicine, particularly in cancer research. The findings suggest that these studies are primarily conducted by collaborations between researchers and industry actors, aiming to provide evidence of clinical utility for proprietary genomic assays. The studies are funded by industry and the majority of authors have industry affiliations. The study emphasizes the need for further research into the impact of these studies on coverage and reimbursement decision-making.

PLOS ONE (2023)

Article Health Policy & Services

How can entrepreneurs experience inform responsible health innovation policies? A longitudinal case study in Canada and Brazil

Pascale Lehoux, Hudson Pacifico Silva, Fiona Miller, Jean-Louis Denis, Renata Sabio Pozelli

Summary: In order to promote equity and sustainability in health systems, Responsible Innovation in Health (RIH) calls for policy changes. However, current policies mainly focus on fostering the supply of innovations and neglect the health policies that affect their uptake. This study aims to inform policies that can support RIH by examining the experiences of RIH-oriented entrepreneurs with policies that influence both the supply and demand of their innovations.

INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2023)

Article Environmental Sciences

A qualitative study of what motivates and enables climate-engaged physicians in Canada to engage in health-care sustainability, advocacy, and action

Owen Dan Luo, Yasmeen Razvi, Gurleen Kaur, Michelle Lim, Kelti Smith, Jacob Joel Kirsh Carson, Claudel Petrin-Desrosiers, Victoria Haldane, Nicole Simms, Fiona A. Miller

Summary: More and more healthcare professionals are recognizing the importance of delivering low-carbon sustainable health systems. This study explored how physicians can be motivated and supported in their pursuit of this goal. Through interviews with climate-engaged Canadian physicians, the study identified actions physicians can take to promote sustainable healthcare and the motivators and enablers of physician engagement in this area.

LANCET PLANETARY HEALTH (2023)

No Data Available